7 articles
The Delhi High Court Division Bench set aside an injunction against Natco Pharma in the Novartis Eltrombopag patent dispute. The judgment provides key guidance on patent validity challenges…
This post explores how drug manufacturers leverage secondary patents to manage the patent cliff and maintain exclusivity. A detailed analysis of Entresto’s patent timeline and Indian legal context…
The Patents Amendment Rules 2020 have come into effect in India, bringing notable changes to patent filing and reporting requirements. This bulletin covers updates on patent disputes, TRIPS…
BananaIP is offering free patent and design filings in India for eligible COVID-19 related inventions if applicants adopt the Open COVID Pledge. This initiative aims to encourage innovation…
The UNDP has issued new guidelines aimed at strengthening pharmaceutical patent examination with an emphasis on public health. The guidelines advocate for stricter standards and the use of…
This article analyses how Indian intellectual property is perceived internationally, especially by the United States, and assesses India’s progress over the past decade. It highlights the importance of…
Xiaomi faces a patent dispute in India but continues to offer competitively priced smartphones. The company leverages its agreements with Qualcomm and focuses on risk mitigation while maintaining…